Hematology-Oncology Associates of the Quad-Cities, PC

Lymphoma Trials

CALGB 50202: Intensive Chemotherapy and Immunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma.

CALGB 50501 A Phase II Trial of Bortezomib + Lenalidomide (Revlimid™, CC-5013) For Relapsed/Refractory Mantle Cell Lymphoma.

Home

Providers

Clinical Trials

Services

Patient Info

Links

Directions

Contact Info